Luisa Mestroni

University of Colorado Anschutz Medical Campus — United States

Medicine · Health Sciences

75h-index22.6kcitations451works6.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cardiomyopathy and Myosin Studies(226), Cardiovascular Effects of Exercise(138), Viral Infections and Immunology Research(62), Cardiovascular Function and Risk Factors(45), Cardiac electrophysiology and arrhythmias(42)

Publications429 total

Integration of dilated cardiomyopathy genomics with transcriptomics from the human heart implicates regulatory molecular mechanisms
2026Open Access
Myocardial Recovery With Mechanical Circulatory Support Is Linked to Alternative Splicing and Subcellular Localization of CAMK2D
Circulation·2026Open Access
Activity of Cardiomyocyte Type 3 Deiodinase After Myocardial Infarction Influences Cardiac Recovery in Females
Endocrinology·2025Open Access
Aberrant tissue mechanics and mechanotransduction during heart development in down syndrome
Journal of Biomechanics·2025
Phase Separation Contributes to Pathogenicity for Nonsense Mediated Decay-Escaping Variant Alleles
2025Open Access
Abstract 4358635: Atrial Fibrillation in Genotyped Dilated Cardiomyopathy: Epidemiology and Associated Risk Factors - Insights from the SHaRe Consortium
Circulation·2025
From molecular and cellular mechanisms to models of heart failure
Elsevier eBooks·2025
Sex Differences in Prognosis of Patients With Genetic Dilated Cardiomyopathy
Circulation Heart Failure·2025
Future Development of Arrhythmogenic Risk Scores in Patients with Heart Failure and Inherited Dilated Cardiomyopathy. A Scientific Statement of the Heart Failure Association of the ESC
European Journal of Heart Failure·2025· 1 cited
Impact of Genotype–Phenotype Associations on Prognosis in Dilated Cardiomyopathy
European Journal of Heart Failure·2025· 4 citedOpen Access
Genome sequencing reveals the impact of pseudoexons in rare genetic disease
Genetics in Medicine·2025· 2 citedOpen Access
Prognostic Role of Myocarditis-Like Episodes and Their Treatment in Patients With Pathogenic Desmoplakin Variants
Circulation·2025· 9 citedOpen Access
Abstract Wed111: Upregulation of EHD2 Leads to Connexin 43 Displacement from the Membrane in FILAMIN C Cardiomyopathy
Circulation Research·2025
The contribution of <i>RBM20</i> truncating variants to human cardiomyopathy
2025· 2 citedOpen Access
Genetic and Phenotypic Characterization of Nexilin (NEXN)–Related Cardiomyopathy
JACC Heart Failure·2025· 4 citedOpen Access
Prognostic role of exercise intensity in familial Filamin C truncating variants
Open Heart·2025Open Access
Diagnostic Criteria and Disease Staging for Desmoplakin Cardiomyopathy
2025Open Access
Cytoplasmic CaMKIIδ-B prevents myocardial recovery in heart failure
2025Open Access
Biocompatibility Assessment of an Injectable Carbon Nanotube-Functionalized Reverse Thermal Gel for Cardiac Tissue Engineering Applications
ACS Applied Bio Materials·2025· 4 cited
Proteomic Analysis of Valsartan for Attenuating Disease Evolution in Early Sarcomeric Hypertrophic Cardiomyopathy (VANISH) Clinical Trial
Circulation Heart Failure·2025· 3 cited
page 1 of 22Next →

Frequent Co-authors

Matthew R.G. Taylor(27), Gianfranco Sinagra(23), Sharon Graw(13), Andrea Di Lenarda(11), Dobromir Slavov(11), William J. McKenna(8), Francesca Brun(8), Michael R. Bristow(7), Bruno Pinamonti(7), Mauro Giacca(7), Daniel P. Judge(6), Marco Merlo(5), Hugh Calkins(5), Cynthia A. James(5), Gregory M. Marcus(5), Wojciech Zaręba(5), Elisa Carniel(5), Debra A. Ferguson(5), Arturo Falaschi(5), Teisha J. Rowland(5)